Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Busulfan Conditioning for HSCT in Childhood and Adolescent ALL
NCT02047578Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2014
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of busulfan in acute lymphoblastic leukemia (ALL), sponsored by Seoul National University Hospital. Primary endpoint: Event-Free Survival at 1 year. Status: unknown.
02
Drugs
busulfan
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02047578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047578.